AMETEK Announces Record Second Quarter 2026 Results and Raises Full Year Guidance
Buy AME now; expect outperformance within 3–6 months on stronger demand and higher guidance.
Signal detail
Source-backed analysis, the reasoning behind the signal, and its market context.
Buy AME now; expect outperformance within 3–6 months on stronger demand and higher guidance.
What happened and why it matters
AMETEK posted a record Q2 2026 with $2.04B in sales, up 15% year over year, and adjusted EPS of $2.09. GAAP EPS was $1.77; orders climbed 28%, underpinning guidance for roughly 10% 2026 revenue growth and a higher full-year EPS target for the year. The raise reflects durable demand across niche markets and acquisitions, supporting potential inventory and margin expansion into the back half.
Surging quarterly performance, record margins, and raised 2026 guidance reduce execution risk and imply higher near-term earnings power; potential for multiple expansion as investors reassess the Growth Model and inorganic contribution.
Q2 2026 sales hit $2.04B, +15% YoY. GAAP EPS: $1.77.
Adjusted EPS up 17% to $2.09; adjusted op income $544.4M.
Orders up 28% in Q2; strong gains across EIG and EMG.
Guidance raised: 2026 sales up ~10%; adjusted EPS $8.20–$8.30.
Category: Earnings. AMETEK's beat-and-raise reflects ongoing execution under the AMETEK Growth Model and suggests sustained demand in secular growth markets; supports multiple expansion potential as visibility improves on integration of acquisitions.
More AI-analyzed coverage connected to this story